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Abstract
Background: Coronary atherosclerosis, the main cause of cardiovascular disease, is a progressive disease. Recent Genome
Wide Association Studies (GWASs) discovered several novel loci associated with coronary artery disease (CAD) or its main
complication myocardial infarction (MI). In this study, we investigated the associations between previously reported CAD-
and MI-associated variants and coronary atherosclerosis in Chinese Han population.
Methodology/Principal Findings: We performed a case-control association study with 2,335 coronary atherosclerosis
patients and 1,078 controls undergoing coronary angiography of Chinese Han from China. Fourteen single nucleotide
polymorphisms (SNPs), located at 1p13.3, 1q41, 2q36.3, 6q25.1, 9p21.3, 10q11.21 and 15q22.33, were genotyped in our
sample collection. Six SNPs at 9p21 were associated with coronary atherosclerosis susceptibility (Ptrend,0.05) and
rs10757274 showed the most significant association (P=2.38610
208, OR=1.34). These associations remained significant
after adjustment for multiple comparisons. Rs17465637 at 1q41 (Ptrend=6.83610
203, OR=0.86) also showed significant
association with coronary atherosclerosis, but the association was not significant after multiple comparisons. Additionally,
rs501120 (P=8.36610
203, OR=0.80) at 10q11.21 was associated with coronary atherosclerosis in females, but did not show
association in males and all participants. Variants at 1p13.3, 2q36.3, 6q25.1 and 15q22.33 showed no associations with
coronary atherosclerosis and main cardiovascular risk factors in our data.
Conclusions/Significance: Our findings indicated variants at 9p21 were significantly associated with coronary
atherosclerosis in Han Chinese. Variants at 1q41 showed suggestive evidence of association and variants at 10q11.21
showed suggestive evidence of association in females, which warrant further study in a larger sample.
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Introduction
Coronary atherosclerosis is a progressive disease and the poten-
tial consequences in atherosclerosis include: coronary artery disease
(CAD) and its main complication myocardial infarction (MI). CAD
and MI are leading causes of death and disability worldwide and
have a rapidly increasing incidence in developing countries [1].
Epidemiological studies have revealed that both genetic and envi-
ronmental risk factors contributed to the pathogenesis of athero-
sclerosis [2]. However, the molecular mechanism of atherogenesis,
including formation, proliferation and atheroma rupture, has not
yet been clarified.
Biological complexity of atherosclerosis implies involvement
of a large number of genes and their functional variants in its
pathogenesis [3]. During the past five decades, large-scale epide-
miological studies and genetic association analysis have identified
multiple risk factors and susceptibility genes for coronary athe-
rosclerosis [4]. Variants of several functionally important genes,
including ApoE [5] and LDLR [6], have been implicated in sus-
ceptibility to coronary atherosclerosis in general population. With
improved genotyping technologies and the completion of the
human HapMap project, Genome-Wide Association Studies
(GWASs) have recently become an important research method
in genetics study. Recent GWASs and meta-analysis in CAD
and MI identified several new susceptibility loci [7,8,9,10,11,12].
Among these loci, the strongest association signals were on
chromosome 9p21.3, which were also correlated with stroke,
abdominal aortic and intracranial aneurysms in several other
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20833cohorts [13]. Variants on chromosome 1p13.3 was also found to
be significantly associated with CAD and LDL cholesterol concen-
tration in recent GWASs [14,15,16,17,18], reinforcing the mecha-
nistic relationship between the variability in LDL levels and CAD
risk [19].
Most of these GWASs were conducted in Caucasian populations,
and several replication studies have been performed in Chinese
population from China. Rs2383206 and rs2383207 were investi-
gated association with CAD in 1,360 cases and 1,360 gender-
matched controls of Chinese Han, and only rs2383207 locus was
found tobe significantly associated withCAD[20].Theassociations
of rs10757274, rs2383206, and rs10757278 were investigated with
MI in Chinese Han subjects by conducting a hospital-based case–
control study (432 cases and 430 controls), and all the three SNPs
showed association with MI [21]. Rs1333049 were found to be an
independent determinant for coronary plaque progression in 1,034
non-diabetic patients but not in 1,012 type 2 diabetic mellitus
(T2DM) patients from Chinese Han [22]. Rs2383206, rs1004638
and rs10757278, in a strong linkagedisequilibrium (LD) block, were
investigated in 510 CAD patients, 558 patients with ischemic stroke
and 557 shared controls of Chinese Han, and showed significant
associations with CAD and weak association with Ischemic Stroke
[23]. Four SNPs at 9p21 were genotyped in 425 MI patients, 687
patients with ischemic stroke, and 1,377 healthy controls recruited
from Chinese population residing in Taiwan, and the result showed
Genetic variationsinthe9p21 regionareassociated with MIbutnot
with stroke [24]. All the above-mentioned studies in Chinese
population were limited to 9p21 variants.
Here, we undertook a replication study in a large cohort of
coronary atherosclerosis patients and controls from Chinese Han
population. We examined 14 SNPs located in seven chromosome
regions which showed strong or moderate associations with CAD
and MI from recent GWASs [7,8,9,10]. Among these new risk loci,
variants at 9p21.3 have been firmly validated in the follow-up
replication studies from different populations [20,25,26,27]. Since
the initial GWASs were conducted in Caucasian populations of
which the LD pattern is quite different from that of Chinese, and the
mostsignificantassociatedSNPwasalsodifferentinseparatestudies,
fine-mapping of 9p21.3 in Chinese population is needed. We
selected eight SNPs, which represent the most associated and
independent SNPs at 9p21.3 in the previous studies, to perform a
limited investigation of the associations of the region in Han Chinese.
Results
Clinical and biochemical characteristics according to the
presence of significant coronary stenoses are summarized in
Table 1. As anticipated, the prevalence of established cardiovas-
cular risk factors was higher in coronary atherosclerosis cases than
that in controls. Overall, the characteristics of our patients were
typical for patients undergoing coronary angiography for the
evaluation of coronary atherosclerosis, with a male preponderance
(61.8%) and a high prevalence of T2DM (15.8%), hypertension
(59.5%), smoking (30.1%) as well as drinking (10.7%). Notably, the
levels of serum LDL cholesterol were significantly lower but HDL
cholesterol levels were higher in patients with significant coronary
stenoses than in patients without such lesions.
Among the 14 SNPs, rs17228212 with a minor allele frequency
(MAF) of less than 1% was removed from further association
analysis. In addition, rs7044859 with Hardy-Weinberg equilibri-
um (HWE) of p,0.01 in controls were also eliminated from
further analysis (Table 2). Twelve SNPs conformed to HWE were
investigated association in 2,335 coronary atherosclerosis patients
and 1,078 control subjects. The LD structure among seven SNPs
conformed to HWE at 9p21.3 was examined by program
Haploview 4.2 (Figure 1A).
Association analysis of the 12 SNPs was performed by using
genotype and Cochran-Armitage trend tests. Of the 12 SNPs,
seven SNPs showed associations with coronary atherosclerosis:
rs17465637 at 1q41 (Ptrend=6.83610
203, OR=0.86, 95% CI=
0.7720.96), and six SNPs at 9p21: rs496892 (Ptrend=3.13610
203,
OR=0.85, 95% CI=0.762 0.95), rs10757274 (Ptrend=2.38610
208,
OR=1.3, 95% CI=1.221.4), rs2383206 (Ptrend=2.77610
207,O R =
1.3, 95%CI=1.221.5), rs2383207 (Ptrend=1.54610
204,O R = 0 . 8 1 ,
95% CI=0.7220.90), rs10757278 (Ptrend=6.52610
207,O R = 0 . 7 7 ,
95% CI=0.6920.85), rs1333049 (Ptrend=8.57610
206,O R = 0 . 7 9 ,
95% CI=0.7120.88) (Table 3). After accounting for the most
significant SNPs rs10757274, no other SNPs at 9p21.3 were
independently associated with coronary atherosclerosis in logistic
regression analysis, suggesting rs10757274 could solely account for
the association signal of this region (Table 4). All the seven SNPs
Table 1. Clinical and biochemical characteristics of participants included in the current study.
Variable Controls (n=1078) Cases (n=2335) P value
Men (%) 50.8 66.9 ,0.001
Ever and current smokers (%) 22.9 33.4 ,0.001
Ever and current drinkers (%) 9.3 11.4 0.069
Hypertension(%) 51.1 63.7 ,0.001
Diabetes (%) 7.0 19.9 ,0.001
Age(years): mean 6 SD 60.4610.3 65.4610.2 ,0.001
Height (CM): mean 6 SD 164.9867.90 166.3767.61 ,0.001
Weight (KG): mean 6 SD 67.00611.23 67.96610.60 0.015
BMI: mean 6 SD 24.5763.41 24.4863.06 0.487
Total cholesterol (mmol/L): mean 6 SD 4.6661.00 4.7761.22 0.009
Triglyceride (mmol/L): mean 6 SD 1.6460.92 1.7661.10 0.001
HDL-C (mmol/L): mean 6 SD 1.2660.37 1.1760.40 ,0.001
LDL-C(mmol/L): mean 6 SD 2.7660.80 2.9060.97 ,0.001
SD, standard deviation: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
doi:10.1371/journal.pone.0020833.t001
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PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e20833remained significant after adjustment for age and sex. Rs599839 at
1p13.3 was not associated with coronary atherosclerosis in univariate
analyses; however, it showed a nominal association after adjusting for
age and sex (Table 3). We also investigated associations in a
multivariate model including age, sex, rs17465637 at 1q41, rs599839
at 1p13.3 and rs10757274 at 9p21.3, and all three SNPs remained
significant (P=0.009 for rs17465637, P=0.02 for rs599839, and
P=3.83 610
207for rs10757274).
Previous studies have suggested sex-specific heritability of
coronary atherosclerosis disease [28,29]. To address this issue,
we performed stratified association analysis by sex. Rs17465637 at
1q41 and rs496892 at 9p21, which showed association in all the
participants, were associated with coronary atherosclerosis in the
female subgroup but not in males. Rs501120 at 10q11.21 was
associated with disease in female group (Pfemale=7.53610
203), but
did not show association in males and all participants. Addition-
ally, rs2383207 was associated with disease in the male subgroup
but not in the females. We also performed association analysis
between the selected SNPs and the known risk factors for coronary
atherosclerosis (hypertension and diabetes). And we found seven
SNPs at 9p21 were associated with susceptibility of atherosclerosis
complicated by hypertension, and five SNPs in block 2 at 9p21
showed associations in non-hypertension subgroup (Figure 1A). In
the cohort without diabetes, the distributions of rs599839 at
1p13.3, rs17465637 at 1q41 and seven SNPs at 9p21 showed
significant differences between cases and controls. We found no
evidence for association with the 6q25.1, 2q36.3 and 15q22.33
loci. The results were summarized in Table 5.
Finally, we examined serum lipid levels with respect to geno-
types of the twelve variants. In univariate analyses, rs17465637 at
1q41 was associated with HDL cholesterol (P=0.018); no other
SNPs showed association with serum LDL cholesterol and HDL
cholesterol. SNP rs599839 at 1p13.3 was associated with plasma
levels of total and LDL cholesterol inprevious studies [14,15,16,17];
however, showed no evidence of association in our data (Table 6).
Discussion
Coronary atherosclerosis, the primary cause of CAD, is a
progressive disease. MI is the last step in the development of
CAD, and thrombogenic factors ultimately determine whether or
not infarction occurs [11,12]. In the past few years, a number of
novel susceptibility genes of CAD or MI were identified using
GWASs. In particular, several SNPs identified by the WTCCC,
McPherson et al and Helgadottir et al met the criteria for
genome-wide association [7,8,10,30]. Other studies found asso-
ciations of these variants with myocardial infarction [25,27,31].
Potential associations between variants on these risk loci and an-
giographically characterized coronary atherosclerosis are un-
known, although some investigations had been made [32]. We
therefore aimed at investigating the association of these reported
variants with coronary atherosclerosis in a large Chinese popu-
lation consisted of well-characterized patients and controls. Our
data validated the variation at 9p21 for association with coronary
atherosclerosis, and provided evidence for the association of
rs17465637 at 1q41.
Variants at 9p21 showed association with genome-wide signi-
ficance in our Chinese Han collection. Rs10757274 was the most
significant SNP among the seven SNPs in this region, and after
accounting for rs10757274, no other SNPs at 9p21.3 showed
association signal. Rs10757274 was also the most significant SNP
in the GWAS by McPherson et al. [8]. However, rs1333049 was
most significantly associated with CAD risk in the GWASs by the
WTCCC and the German Cardiogenics Consortium [9,10], and
rs10757278 was the lead SNP in the GWAS of MI by Helgadottir
et al. [7]. Indeed, rs1333049 and rs10757278 were in complete LD
in both CEU and CHB data from HapMap, but were in low LD
(r
2=0.32) in the YRI data from HapMap. The LD between
rs1333049 and rs10757274 were also high in both CEU and CHB
data from HapMap (r
2.0.89), as well as in our study (r
2=0.76)
and previous ones (r
2=0.89) [33] (Figure 1A–B). Since the LD in
this critical region is strong, using a population with low LD may
Figure 1. LD plot of SNPs in chromosome 9p21.3. (A) LD plot of
seven SNPs in chromosome 9p21.3 of Chinese Han population from
current study. The r
2 values were estimated from data of 2,335
atherosclerosis patients and 1,078 controls enrolled in the current study;
(B) LD structure of six risk SNPs at 9p21.3 in CEU population (Europeans)
fromthe dataofHapMap phaseII release 23. Weconstructed the plotwith
Haploview 4.2 [47], and r
2 (6100) values were depicted in the diamonds.
Blocks were determined using the default method of Gabriel et al [48].
doi:10.1371/journal.pone.0020833.g001
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therefore aid downstream analysis in future study.
The nearest described protein coding genes of these risk variants
within chromosome 9p21 are CDKN2A/2B which encode inhi-
bitors of CDK4/CDK6. The CDKN2A gene generates two tran-
scripts derived from the alternative first exons, E1a and E1b, which
incorporate exon 2 and 3 encoding p16/CDKN2A and p14/ARF,
respectively [34]. A fourth gene, MTAP, is located further upstream
in close proximity. All these genes play roles in cancer, cell-cycle
control, apotosis and aging; however, their roles in the pathogenesis
of atherogenesis are not clear. A new discovered large antisense
noncoding RNA (designated antisense noncoding RNA in the
INK4 locus, ANRIL) embedded in these genes, with a first exon
located in the promoter of the p14/ARF gene and overlapping the
two exons of p15/CDKN2B [35]. Previous studies showed that
ANRIL was expressed in atherosclerotic tissue [36] and the ex-
pression of ANRIL was coordinated with that of p14/ARF and
possibly with p16/CDKN2A and p15/CDKN2B in both physiological
and pathological conditions [35,37], suggesting that it might
regulate the expression of these genes. The expression of ANRIL
transcripts (EU741058 and NR_003529) in atherosclerotic plaque
tissue was directly correlated with severity of atherosclerosis;
however, no such correlation was found in CDKN2A, CDKN2B
and MTAP [32]. Taken together, ANRIL might play a role in the
pathogenesis of atherosclerosis. On the other hand, targeted
deletion of the 9p21 non-coding interval in mice provided direct
evidence that the risk interval has a pivotal role in regulation of
cardiac CDKN2A/B expression, and suggested that this region
affects CAD progression by altering the dynamics of vascular cell
proliferation [38].
On chromosome 1q41, SNP rs17465637 was associated with
coronary atherosclerosis in our study (Ptrend=6.83610
203, OR=
0.86, 95% CI=0.7720.96) and also showed moderate association
with HDL cholesterol (P=0.02). Rs17465637 was firstly reported
to be associated with CAD in a GWAS by samani et al. [9]. And
then, it was reported to be associated with early-onset MI in the
GWAS by Myocardial Infarction Genetics Consortium [39] and
the association with MI was replicated in a Japanese sample [31].
However, in a large-scale association study from nine European
studies, rs17465637 showed no significant association with CAD;
instead, a SNP (rs3008621) in an adjacent haplotype block showed
significant association [19]. Both rs17465637 and rs3008621 were
located in the intron region of the melanoma inhibitory activity
family, member 3 (MIA3) gene (also known as ARNT or TANGO).
Table 3. Association analyses of the selected SNPs in 2,335 coronary atherosclerosis patients and 1,078 controls.
Chr Position SNP P genotype
* P trend
* OR (95% CI) P adjusted
a* OR (95% CI)
a*
1 109623689 rs599839 0.09 0.07 0.83 (0.68–1.02) 0.02 0.77 (0.62–0.96)
1 220890152 rs17465637 0.02 6.83610
203 0.86 (0.77–0.96) 3.71610
203 0.85 (0.76–0.95)
2 226776324 rs2943634 0.5 0.60 0.95 (0.79–1.14) 0.63 0.95 (0.79–1.16)
6 151294678 rs6922269 0.61 0.59 0.90 (0.61–1.33) 0.64 0.91 (0.60–1.37)
9 22014351 rs496892 0.01 3.13610
203 0.85 (0.76–0.95) 0.01 0.87 (0.78–0.97)
9 22021005 rs7865618 0.13 0.05 0.85 (0.72–1.00) 0.14 0.88 (0.74–1.05)
9 22086055 rs10757274 1.83610
207 2.38610
208 1.34 (1.21–1.48) 5.14610
208 1.37 (1.22–1.53)
9 22105026 rs2383206 1.21610
206 2.77610
207 1.32 (1.19–1.46) 4.36610
207 1.33 (1.19–1.49)
9 22105959 rs2383207 4.56610
204 1.54610
204 0.81 (0.72–0.90) 4.23610
204 0.81 (0.72–0.91)
9 22114477 rs10757278 5.20610
206 6.52610
207 0.77 (0.69–0.85) 2.08610
206 0.77 (0.69–0.86)
9 22115503 rs1333049 6.95610
205 8.57610
206 0.79 (0.71–0.88) 1.28610
205 0.79 (0.70–0.88)
10 44073873 rs501120 0.33 0.19 0.93 (0.84–1.04) 0.12 0.91 (0.81–1.02)
OR, odds ratio; 95% CI, 95% confidence interval.
aThe adjusted P-value and OR in multiple logistic regression after adjustment for age and sex.
*P-value of ,0.05 was considered statistically significant, and P ,0.0036 was considered significant after Bonferroni correction for 14 SNPs.
doi:10.1371/journal.pone.0020833.t003
Table 4. Logistic regression analysis of 9p21.3 associated with atherosclerosis in Chinese Han population.
Chr rs Position OR (95% CI)
Single-locus
test P
r
2 with
rs10757274
Single-locus test P when
SNP added to rs10757274
Single-locus test P when
rs10757274 added to SNP
9 rs496892 22014351 0.85 (0.76–0.95) 3.13610
203 0.17 0.52 6.90610
207
9 rs7865618 22021005 0.85 (0.72–1.00) 5.17610
202 0.07 0.67 5.32610
207
9 rs10757274 22086055 1.34 (1.21–1.48) 2.38610
208 // /
9 rs2383206 22105026 1.32 (1.19 - 1.46) 2.77610
-07 0.87 0.45 5.83610
-03
9 rs2383207 22105959 0.81 (0.72 - 0.90) 1.54610
-04 0.38 0.61 4.44610
-05
9 rs10757278 22114477 0.77 (0.69 - 0.85) 6.52610
-07 0.77 0.89 0.01
9 rs1333049 22115503 0.79 (0.71–0.88) 8.57610
206 0.75 0.43 7.57610
204
The single–locus tests were restricted to complete genotypes for each SNP in the separate region.
OR, odds ratio for the minor allele; 95% CI, 95% confidence interval; r
2, the coefficient of LD between rs10757274 and the additional SNPs.
doi:10.1371/journal.pone.0020833.t004
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function, was originally identified as a new member of MIA gene
family. MIA3 is widely expressed in vivo in contrast to the highly
restricted expression pattern for the other family members [40].
Arndt et al. observed that MIA3 expression was induced after
adhesion of human monocytic cells to the substrate and found that
recombinant MIA3 protein could reduce attachment of human
monocytic cells to fibrinogen, ICAM-1 and human microvascular
endothelial cells (HMECs). Additionally, the migrating capacity of
premonocytic cells through fibrinogen or HMECs was increased
after stimulation of these cells with recombinant MIA3. These
results suggested that MIA3 reduced the attachment to fibrinogen
or other cell adhesion molecules [41]. This process is fundamental
for the formation and progression of atherosclerotic plaque and
also for plaque instability, which might play an important role in
the development of coronary atherosclerosis.
Rs501120 at 10q11.21 lies upstream of the CXCL12 gene
which codes for stromal cell-derived factor-1 (SDF-1), a member of
the family of chemoattractant cytokines known as chemokines and
is the ligand for cell-surface chemokine receptor 4. SDF-1 has high
expression in smooth muscle cells, endothelial cells, and macro-
phages in human atherosclerotic plaques, and was reported to be
involved in the induction of platelet aggregation [42]. The
combined analysis of The WTCCC study and the German MI
study revealed that rs501120 at 10q11.21 was associated with
CAD for the first time [9]. In 11,550 CAD cases and 11,205 con-
trols from 9 European studies, rs501120 was replicated association
with CAD and showed a stronger association in women than in
men [19]. In our study, the SNP was associated with coronary
atherosclerosis in women but not in man and all participants
(Pall=0.19, Pfemale=8.36610
203,P male=0.67). These results suggested
that rs501120 might affect the pathology of atherosclerosis with sex
difference, and the mechanism requires further investigation.
SNP rs599839, on chromosome 1p13.3, has recently been
reported to be associated with CAD [9,19] and LDL-cholesterol
in several GWASs [14,15,16,17], and the association with lipid
concentrations were replicated in a Japanese population [43]. In
univariate analyses of our study, SNP rs599839 was not associated
with coronary atherosclerosis as well as serum lipids level;
however, the association appeared significant after adjusting for
age, sex and other significant SNPs in multivariate analyses.
Assuming the prevalence of 0.50 and using a significance level of
0.05, our study had only 24.6% power to detect association with
rs599839 (MAF of 7.3%) in 2,335 CAD patients vs. 1,078 controls.
Table 5. Association analyses of the selected SNP and atherosclerosis with risk factors.
Chr Position SNP P female P male P hypertension P non-hypertension P diabetes P non- diabetes
1 109623689 rs599839 0.30 0.06 0.71 0.05 1.00 0.04
1 220890152 rs17465637 0.02 0.10 0.05 0.07 0.11 0.01
2 226776324 rs2943634 1.00 0.57 0.61 1.00 0.24 0.84
6 151294678 rs6922269 0.55 0.18 0.58 1.00 1.00 0.68
9 22014351 rs496892 0.03 0.07 1.38610
204 0.84 0.85 2.85610
203
9 22021005 rs7865618 0.82 0.06 3.38610
203 0.70 0.39 0.03
9 22086055 rs10757274 2.18610
203 1.45610
205 4.52610
204 4.03610
205 0.16 2.54610
207
9 22105026 rs2383206 6.04610
203 1.86610
205 7.64610
204 5.69610
205 0.13 1.48610
206
9 22105959 rs2383207 0.05 2.55610
203 0.03 1.78610
203 1.00 2.81610
205
9 22114477 rs10757278 0.01 3.79610
205 6.53610
204 3.17610
204 0.24 8.66610
207
9 22115503 rs1333049 0.02 1.95610
204 3.08610
203 9.00610
204 0.33 1.55610
205
10 44073873 rs501120 8.36610
203 0.67 0.77 0.09 0.52 0.23
doi:10.1371/journal.pone.0020833.t005
Table 6. Distribution of serum lipid levels in the study according to genotypes of rs599839 and rs17465637.
Total cholesterol (mmol/l) ± SD Triglycerides (mmol/l) ± SD HDL-C (mmol/l) ± SD LDL-C (mmol/l) ± SD
rs599839
GG (9) 4.9660.77 1.7360.68 1.2960.26 2.9461.03
GA (416) 4.6661.16 1.6461.07 1.2160.33 2.8360.97
AA (2900) 4.7361.16 1.7361.04 1.2060.40 2.8560.91
P value 0.39 0.27 0.75 0.85
rs17465637
AA (486) 4.7861.10 1.6860.99 1.2560.59 2.8460.96
AC (1499) 4.6961.19 1.7061.03 1.1960.33 2.8360.90
CC (1310) 4.7861.13 1.7861.09 1.1960.35 2.8860.92
P value 0.12 0.09 0.02 0.35
SD, standard deviation; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
doi:10.1371/journal.pone.0020833.t006
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should be performed to evaluate the association of rs599839 to
CAD susceptibility and lipid serum lipids level.
Variants at 2q36.3, 6q25.1, 10q11.21 and 15q22.33 showed no
associations in our data, and the following reasons might explain
for the lack of association with atherosclerosis. First, the minor
allele frequency of certain SNPs (rs6922269 and rs17228212) were
low (MAF ,5%) in Chinese population, and the sample size of
our study was moderate, which has limited our power to detect the
association. Therefore, further study with even larger sample size
was needed to assess the associations. Second, previous GWASs
might uncover risk alleles in these regions important for popu-
lations of Caucasians descent which may not contribute much to
risk in Chinese due to different environment or other gene inter-
actions, and therefore we did not replicated the associations of
these region using the SNPs uncovered previously.
In conclusion, we have confirmed genetic associations for
coronary atherosclerosis with 9p21. Additionally, our data
showed suggestive evidence of association at 1q41 and sugges-
tive evidence of association at 10q11.21 in females, which war-
rant further study in a larger sample. These findings provided a
strong foundation for further investigation of these loci as risk
factors for coronary atherosclerosis in Chinese Han population.
Materials and Methods
Ethics Statement
Approval to undertake this study was granted by the Ethics
Review Committee of the Chinese National Human Genome
Center at Shanghai and was conducted according to the Dec-
laration of Helsinki Principles. Written informed consent was
obtained from each recruited subjects.
Study Populations
A total of 3,413 individuals were included in this study,
consisting of 2,335 atherosclerosis patients and 1,078 unrelated
controls free of atherosclerosis. Samples were collected from the
cardiovascular care units of three hospitals in Shanghai. To reduce
the potential confounding from ethnic backgrounds, we only en-
rolled people with self-reported origin of central Han Chinese,
including indigenous people from Shanghai, Zhejiang Province,
Jiangsu Province and Anhui Province. Recent analyses by
Genome-wide SNP variation have shown that the central Han
Chinese could be regarded as one single homogenous population
[44,45]. The diagnosis of coronary atherosclerosis was made on
the basis of coronary angiography. Consensus diagnosis of coro-
nary atherosclerosis was performed by two experienced doctors,
who carefully evaluated the status by medical history, stenosis
status and physical examination. Individuals with at least 50%
atherosclerosis occlusion in more than two branches of the
coronary artery were included as cases in the current study. All
controls were individuals without coronary sterosis. Those with
coronary myocardial bridge were excluded from the study. At
enrollment, anthropometric measures, medication usage and
family history data were collected from each subject by a trained
interviewer. The demographic and risk factor information of all
case and control samples were summarized in Table 1. Genomic
DNA of all samples was isolated from whole blood using
FlexiGene DNA Kit (Qiagen, Valencia, CA, USA).
SNP selection and genotyping
Fourteen SNPs associated with CAD or MI from recent
GWASs were studied, including those identified by McPherson
et al (rs10757274 and rs2383206 at 9p21.3) [8], Helgadottir et al
(rs2383207 and rs10757278 at 9p21.3) [7], Samani et al (rs599839
at 1p13.3, rs17465637 at 1q41, rs2943634 at 2q36.3, rs6922269 at
6q25.1, rs501120 at 10q11.21, rs17228212 at 15q22.33 and four
tag SNPs of two blocks at 9p21.3 including: rs7044859, rs496892,
rs7865618 and rs1333049) [9].
Eight SNPs (rs599839, rs6922269, rs10757278, rs2383206,
rs7865618, rs501120, rs10757274 and rs17228212) were geno-
typed using SNPStream (Beckman Coulter, Fullerton, CA). Primer
design for PCR and single base extension (SBE) was performed
with Beckman Coulter Autoprimer software. Another six SNPs
(rs17465637, rs2943634, rs1333049, rs496892, rs2383207 and
rs7044859) were genotyped using TaqMan chemistry (Applied
Biosystems). TaqMan genotyping assays with probes labeled with
the fluorophores FAM and VIC were purchased from Applied
Biosystems. The Universal PCR Master Mix from Applied
Biosystems was used in a 5 ml total reaction volume with 10 ng
DNA per reaction. Allelic discrimination was measured automat-
ically on ABI Prism 7900HT (Applied Biosystems) with Sequence
Detection Systems 2.1 software (auto caller confidence level, 95%).
To evaluate the concordance of the two platforms, we selected
rs1333049 to be re-genotyped in 100 randomly selected samples
by using the SNPStream system. The concordance rate between
the genotypes from the TaqMan and the SNPStream was 99%.
Statistical analysis
Genotype distributions were evaluated for departure from HWE
by Plink software [46] (version 1.07, http://pngu.mgh.harvard.
edu/purcell/plink/). We performed genotype and Cochran-Armi-
tage trend tests to assess genotype-phenotype association using Plink
software. Allele frequencies for cases and controls were used to
calculate the Odds Ratio (OR) and the 95% Confidence Interval
(CI). Conditional logistic regression was performed to assess
whether the most significant SNP in the associated region was
sufficient to model the association. Multiple logistic regression was
used to evaluate if each SNP was independently associated with
CAD and serum lipid levels when adjusted for age and sex.
Continuous data were expressed as mean 6 standard deviations
(SD) and independent-samples t-test was employed to analyze
differencesbetweentwo studygroups.A two tailed P-value of,0.05
was considered statistically significant, whereas a value of corrected
P,0.0036 was considered significant after Bonferroni correction for
14 SNPs. The software used for statistical calculations was the SPSS
15.0 (SPSS Inc., Chicago, IL, USA) unless specified.
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